b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="plosmed" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2100141/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100141/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS Medicine" /><meta name="citation_title" content="Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group" /><meta name="citation_authors" content="David Montefiori, Quentin Sattentau, Jorge Flores, Jos\xc3\xa9 Esparza, John Mascola, on behalf of a Working Group convened by the Global HIV Vaccine Enterprise" /><meta name="citation_date" content="December 2007" /><meta name="citation_issue" content="12" /><meta name="citation_volume" content="4" /><meta name="citation_doi" content="10.1371/journal.pmed.0040348" /><meta name="citation_pmid" content="18052607" /><meta name="DC.Title" content="Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Public Library of Science" /><meta name="DC.Contributor" content="David Montefiori" /><meta name="DC.Contributor" content="Quentin Sattentau" /><meta name="DC.Contributor" content="Jorge Flores" /><meta name="DC.Contributor" content="Jos\xc3\xa9 Esparza" /><meta name="DC.Contributor" content="John Mascola" /><meta name="DC.Contributor" content="on behalf of a Working Group convened by the Global HIV Vaccine Enterprise" /><meta name="DC.Date" content="2007 Dec" /><meta name="DC.Identifier" content="10.1371/journal.pmed.0040348" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group" /><meta property="og:type" content="article" /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100141/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosmed.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2100141/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2100141/pdf/pmed.0040348.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1AB7E1E99A0FA100000000090C090B.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/277/">PLoS Med</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/160274/">v.4(12); 2007 Dec</a></li><li class="accid">PMC2100141</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosmed.gif" alt="Logo of plosmed" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS Medicine" title="PLoS Medicine" href="http://www.plosmedicine.org/" ref="reftype=publisher&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosmedicine.org/static/checklist.action" ref="reftype=publisher&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosmedicine.org/static/contact.action" ref="reftype=publisher&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org" ref="reftype=publisher&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pmed.0040348" ref="reftype=publisher&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">PLoS Med</span>. 2007 Dec; 4(12): e348. </span></div><div><span class="fm-vol-iss-date">Published online 2007 Dec 1. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1371%2Fjournal.pmed.0040348" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pmed.0040348</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2100141</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/18052607">18052607</a></div></div></div></div><h1 class="content-title">Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions</h1><div class="fm-subtitle">A summary report from a Global HIV Vaccine Enterprise Working Group</div><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Montefiori%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18052607">David Montefiori</a>,<sup>&#x0002a;</sup> <a href="/pubmed/?term=Sattentau%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18052607">Quentin Sattentau</a>, <a href="/pubmed/?term=Flores%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18052607">Jorge Flores</a>, <a href="/pubmed/?term=Esparza%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18052607">Jos&#x000e9; Esparza</a>, <a href="/pubmed/?term=Mascola%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18052607">John Mascola</a>, and  on behalf of a Working Group convened by the Global HIV Vaccine Enterprise</div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139650092087776_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139650092087776_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139650092087776_ai" style="display:none"><div id="cor1">&#x0002a; To whom correspondence should be addressed. E-mail: <a href="mailto:dev@null" data-email="ude.ekud@etnom" class="oemail">ude.ekud@etnom</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139650092087776_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2007 Montefiori et al.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>See "<a href="/pmc/articles/PMC2100140/">HIV Treatment Proceeds as Prevention Research Confounds</a>" , e347.</div><div style="border-top: 1px solid rgb(102, 102, 153); margin: 5px 10% 3px;"></div><div>This article has been <a href="/pmc/articles/PMC2100141/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139650169209376" class="tsec sec headless whole_rhythm"><p id="__p2" class="p p-first">The Global HIV Vaccine Enterprise convened a two-day workshop in May of 2007 to discuss humoral immune responses to HIV and approaches to design vaccines that induce viral neutralizing and other potentially protective antibody responses. The goals of this workshop were to identify key scientific issues, gaps, and opportunities that have emerged since the Enterprise Strategic Plan was first published in 2005 [<a href="#pmed-0040348-b001" rid="pmed-0040348-b001" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423014">1</a>], and to make recommendations that Enterprise stakeholders can use to plan new activities.</p><p id="__p3">Most effective viral vaccines work, at least in part, by generating antibodies that inactivate or neutralize the invading virus, and the existing data strongly suggest that an optimally effective HIV-1 vaccine should elicit potent antiviral neutralizing antibodies. However, unlike acute viral pathogens, HIV-1 chronically replicates in the host and evades the antibody response. This immune evasion, along with the large genetic variation among HIV-1 strains worldwide, has posed major obstacles to vaccine development. Current HIV vaccine candidates do not elicit neutralizing antibodies against most circulating virus strains, and thus the induction of a protective antibody response remains a major priority for HIV-1 vaccine development. For an antibody-based HIV-1 vaccine, progress in vaccine design is generally gauged by in vitro assays that measure the ability of vaccine-induced antibodies to neutralize a broad spectrum of viral isolates representing the major genetic subtypes (clades) of HIV-1 [<a href="#pmed-0040348-b002" rid="pmed-0040348-b002" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423033">2</a>]. Although it is not known what magnitude and breadth of neutralization will predict protection in vaccine recipients, it is clear that current vaccine immunogens elicit antibodies that neutralize only a minority of circulating isolates. Thus, much progress needs to be made in this area. Also, though virus neutralization is considered a critical benchmark for a vaccine, this may not be the only benchmark for predicting success with antibody-based HIV-1 vaccine immunogens.</p><p id="__p4">The main targets for neutralizing antibodies to HIV-1 are the surface gp120 and trans-membrane gp41 envelope glycoproteins (Env) that mediate receptor and coreceptor binding and the subsequent membrane fusion events that allow the virus to gain entry into cells [<a href="#pmed-0040348-b003" rid="pmed-0040348-b003" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423047">3</a>]. Antibodies neutralize the virus by binding these viral spikes and blocking virus entry into susceptible cells, such as CD4<sup>&#x0002b;</sup> T cells [<a href="#pmed-0040348-b004" rid="pmed-0040348-b004" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423023">4</a>,<a href="#pmed-0040348-b005" rid="pmed-0040348-b005" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423040">5</a>]. In order to chronically replicate in the host, the virus exploits several mechanisms to shield itself against antibody recognition, including a dense outer coating of sugar molecules (N-linked glycans) and the strategic positioning of cysteine&#x02013;cysteine loop structures on the gp120 molecule [<a href="#pmed-0040348-b006" rid="pmed-0040348-b006" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423024">6&#x02013;8</a>]. These shielding mechanisms, although highly effective, have vulnerabilities imposed by fitness constraints. Information on the precise location and molecular structure of these vulnerable regions could be valuable for the rational design of improved vaccine immunogens.</p><p id="__p5" class="p">Participants in the workshop identified four areas that, if given proper attention, could provide key information that would bring the field closer to an effective antibody-based HIV-1 vaccine: (1) structure-assisted immunogen design, (2) role of Fc receptors and complement, (3) assay standardization and validation, and (4) immunoregulation of B cell responses.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Structure-Assisted Immunogen Design</h2><p id="__p6" class="p p-first">Clinical studies have demonstrated that immunization with the gp120 surface unit of the HIV-1 envelope protein does not lead to the induction of potent or broadly reactive neutralizing antibodies. In order to develop better immunogens, it is likely that we will need a more detailed understanding of the atomic level structure of epitopes on the native envelope glycoprotein. Data on the X-ray crystal structure of liganded and unliganded partial gp120 molecules have provided valuable information about the atomic level interaction of gp120 and neutralizing antibodies [<a href="#pmed-0040348-b009" rid="pmed-0040348-b009" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_692282107">9&#x02013;12</a>]. The recent atomic level resolution of monoclonal antibody (MAb) b12 bound to the CD4 receptor binding site of the gp120 molecule provides new insights into how successful neutralizing antibodies access functionally conserved regions of the Env glycoprotein [<a href="#pmed-0040348-b013" rid="pmed-0040348-b013" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423012">13</a>]. Crystal structures of complete monomeric gp120 and gp120&#x02013;gp41 trimer complexes in their native unliganded form need to be elucidated, as these are the natural targets for neutralizing antibodies. This information is needed for multiple genetic subtypes of the virus and for transmitted strains of the virus. Coupled with this effort should be a program to make necessary improvements in electron tomography technology to gain a higher resolution of native Env spikes as they exist on virus particles [<a href="#pmed-0040348-b014" rid="pmed-0040348-b014" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423041">14&#x02013;16</a>]. An improved understanding of the structural basis of antibody binding to the HIV-1 Env glycoprotein will likely form the foundation for a rational program of novel vaccine design. Ongoing efforts to stabilize gp120 into more immunogenic forms or to scaffold conserved neutralization epitopes into foreign proteins may lead to more promising antibody responses.</p><p id="__p7">Induction of an effective neutralizing antibody response will require that a vaccine deliver to the na&#x000ef;ve B cell repertoire epitopes that are both immunogenic (i.e., possess favorable properties for B cell inductive pathways) and antigenic (i.e., available for high affinity antibody binding on functional Env spikes). Viral epitopes that are conserved among most viral strains are more likely to generate cross-reactive antibodies. In this regard, researchers have focused on a small number of human MAbs, from clade B HIV-1-infected individuals, that possess broadly cross-reactive neutralizing activity [<a href="#pmed-0040348-b017" rid="pmed-0040348-b017" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423035">17</a>,<a href="#pmed-0040348-b018" rid="pmed-0040348-b018" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423038">18</a>]. The cognate viral epitopes for these MAbs have been well characterized and are being evaluated as vaccine immunogens. However, for reasons that are not completely understood, these conserved viral epitopes have either been poorly immunogenic or have elicited antibodies of restricted reactivity. Improvements are being sought by introducing specific structural alterations [<a href="#pmed-0040348-b019" rid="pmed-0040348-b019" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620815713">19</a>,<a href="#pmed-0040348-b020" rid="pmed-0040348-b020" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620815711">20</a>] and by targeting autoreactive B cell pathways [<a href="#pmed-0040348-b021" rid="pmed-0040348-b021" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423027">21</a>]. These and other efforts to improve the immunogenicity of conserved neutralization epitopes should remain a high priority. Workshop participants recognized the need to expand efforts to identify and characterize new MAbs, with special attention to MAbs from non-clade B HIV-1 infections. New technologies are now available that might afford an advantage for identifying novel antibody specificities that were previously undetected [<a href="#pmed-0040348-b022" rid="pmed-0040348-b022" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620815712">22</a>,<a href="#pmed-0040348-b023" rid="pmed-0040348-b023" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423017">23</a>]. In addition to this focus on MAbs, sera from selected HIV-1-infected individuals that can broadly neutralize HIV-1 isolates should be studied in detail. New assays allow more precise mapping of the polyclonal antibody response in these sera to better understand the epitopes targeted [<a href="#pmed-0040348-b005" rid="pmed-0040348-b005" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423016">5</a>,<a href="#pmed-0040348-b024" rid="pmed-0040348-b024" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423028">24&#x02013;26</a>]. Such studies may reveal novel antibody specificities and their associated viral epitopes that could be useful for immunogen design.</p><p id="__p8" class="p p-last">While there has been considerable interest in conserved epitopes, less attention has been paid to more variable epitopes that might be useful if administered in the form of a polyvalent vaccine. Of particular interest are the epitopes that drive the autologous neutralizing antibody response in infected individuals. These epitopes may be quite variable, but recent evidence suggests that there are constraints on the extent of variation the virus can tolerate in these regions [<a href="#pmed-0040348-b027" rid="pmed-0040348-b027" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423043">27</a>,<a href="#pmed-0040348-b028" rid="pmed-0040348-b028" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423032">28</a>]. Detailed molecular and immunologic studies of the autologous neutralization response would enhance our understanding of viral determinants that are vulnerable to antibody attack. Similarly, it is possible that combinations of antibodies will have desirable additive or synergistic effects on virus neutralization [<a href="#pmed-0040348-b029" rid="pmed-0040348-b029" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423019">29&#x02013;32</a>]. An example is seen in how soluble CD4 binding rearranges the structure of gp120 to expose the highly conserved coreceptor binding domain, which allows antibody binding and virus neutralization to occur [<a href="#pmed-0040348-b033" rid="pmed-0040348-b033" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423030">33</a>,<a href="#pmed-0040348-b034" rid="pmed-0040348-b034" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423018">34</a>]. Such effects of antibodies might be discovered by applying high throughput screening methods to the plethora of existing MAbs as well as new MAbs that become available in the future.</p></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Role of Fc Receptors and Complement</h2><p id="__p9" class="p p-first">Recent findings have generated renewed interest in so-called &#x0201c;non-neutralizing&#x0201d; antibodies that are unable to directly inhibit free virus entry into target cells, but nonetheless exhibit antiviral activity mediated by the Fc region of the antibody molecule. These antibody effector mechanisms include complement binding and viral lysis, phagocytosis of antibody-coated virions, and antibody-dependent cellular cytotoxicity [<a href="#pmed-0040348-b035" rid="pmed-0040348-b035" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423046">35&#x02013;38</a>]. Recent studies have suggested examples of Fc-dependent antiviral effects of HIV-1-positive serum in cases where there was little or no detectable activity in conventional neutralization assays [<a href="#pmed-0040348-b039" rid="pmed-0040348-b039" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423025">39</a>,<a href="#pmed-0040348-b040" rid="pmed-0040348-b040" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423049">40</a>].</p><p id="__p10" class="p p-last">In addition, passive transfer studies in a relevant monkey model suggest that Fc receptor (FcR) binding capacity of a protective antibody makes a substantial contribution to the antibody-mediated protection [<a href="#pmed-0040348-b041" rid="pmed-0040348-b041" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423015">41</a>]. Antibody effector functions that mediate complement activation and FcR engagement on macrophages, dendritic cells, natural killer cells, and other cell types need to be evaluated to determine their relevance to HIV-1 vaccines. Assays that measure these antiviral antibodies should be standardized and used to assess biologic relevance in passive protection experiments in animal models using antibodies that exhibit the different effector functions in vitro.</p></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Assay Standardization and Validation</h2><p id="__p11" class="p p-first">In order to adequately monitor neutralization breadth and potency and to compare and prioritize immunogens, assays are needed that are sensitive, quantitative, high throughput, and have correlative value. Substantial improvements have been made in the past several years in assay technology and in available reference reagents. Thus, cumbersome and expensive assays using peripheral blood mononuclear cells (PBMC) and uncloned viruses are being replaced with assays that utilize molecularly cloned Envpseudotyped viruses and genetically engineered target cells lines [<a href="#pmed-0040348-b002" rid="pmed-0040348-b002" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423045">2</a>,<a href="#pmed-0040348-b042" rid="pmed-0040348-b042" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423034">42&#x02013;45</a>]. This new technology affords greater sensitivity, reproducibility, high throughput, and cost-effectiveness compared to PBMC assays, and as a result, it has been responsible for an explosion of new data. Steps are being taken by the Collaboration for AIDS Vaccine Discovery to transfer this new technology to multiple laboratories around the world and to implement a validated proficiency testing program to assure inter-laboratory equivalency in assay performance.</p><p id="__p12">Recently, several cases were identified where neutralization was considerably more potent or only detected in the older PBMC assay compared to the newer assay technology [<a href="#pmed-0040348-b043" rid="pmed-0040348-b043" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423044">43</a>,<a href="#pmed-0040348-b046" rid="pmed-0040348-b046" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423048">46</a>,<a href="#pmed-0040348-b047" rid="pmed-0040348-b047" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423029">47</a>]. This raises important questions about current plans to employ a single assay for routine use, and it points to the need for a better understanding of the mechanisms of neutralization. Thus, it may be necessary to use more than one assay to assure that all neutralizing antibodies are detected. There is a need to standardize and compare neutralizing antibody assays and to decide which assay or combination of assays should be used for standardized assessments of vaccine-elicited neutralizing antibody responses. A major priority is to strengthen the standardization of the PBMC assay, given that it is the only assay that has been at least partially validated in passive antibody experiments in animal challenge models.</p><p id="__p13" class="p p-last">Important decisions need to be made about the types of antibodies and assays that have greatest relevance to HIV-1 vaccines. Validation experiments in animals models are needed to determine the potential correlative value of new assay technologies that rely on the use of genetically engineered cells lines and Envpseudotyped viruses. Ideally, this would be done by employing several different assays to study the antibody response in a clinical efficacy trial in which the vaccine was at least partially protective. Because no such vaccine is currently available for HIV-1, studies in animal models are the next best choice. In this regard, two animal models are widely used for HIV vaccine development: simian immunodeficiency virus (SIV) and chimeric simian-human immunodeficiency virus (SHIV) infection in monkeys [<a href="#pmed-0040348-b048" rid="pmed-0040348-b048" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620815710">48</a>]. Quantitative passive transfer experiments in either model with antibodies that exhibit different effector functions could be used to address the biological relevance of in vitro assays. Unfortunately, very few SHIVs are currently available and, among these, most are derived from a single genetic subtype (clade B) and exhibit properties that may not be well suited to assay validation [<a href="#pmed-0040348-b049" rid="pmed-0040348-b049" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620815709">49</a>]. The creation of new and better SHIVs from non-clade B viruses would facilitate assay standardization as well as vaccine challenge models.</p></div><div id="s5" class="tsec sec"><h2 class="head no_bottom_margin" id="s5title">Immunoregulation of B Cell Responses</h2><p id="__p14" class="p p-first">This workshop identified several critical gaps in the current understanding of B cell regulatory pathways that impede a more rational development of an effective antibody-based HIV-1 vaccine. For example, broadly neutralizing antibodies in patient serum bind epitopes that are present on monomeric gp120 [<a href="#pmed-0040348-b025" rid="pmed-0040348-b025" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423026">25</a>], yet this is a poor immunogen for neutralizing antibody induction in vaccine recipients. Moreover, as mentioned above, viral epitopes for the known broadly neutralizing MAbs appear to be poorly immunogenic in infected individuals and as vaccine candidates. Insights into the immunoregulation of some of these latter epitopes (e.g., epitopes defined by MAbs 2F5 and 4E10) was provided by recent studies in which the MAbs were discovered to bind one or more self antigens [<a href="#pmed-0040348-b050" rid="pmed-0040348-b050" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423031">50</a>,<a href="#pmed-0040348-b051" rid="pmed-0040348-b051" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423039">51</a>], raising the possibility that these antibody specificities are subjected to negative regulation mechanisms, such as receptor editing or deletion. Thus, Env as an immunogen may bypass key steps in the B cell inductive pathway, or may actively induce negative production or downregulation of production of some broadly neutralizing antibodies [<a href="#pmed-0040348-b052" rid="pmed-0040348-b052" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423042">52&#x02013;54</a>].</p><p id="__p15">The receptor&#x02013;ligand interactions and intracellular signaling pathways that govern the production of antibody-producing plasma cells and the persistence of plasma and memory B cells are poorly understood. Additional information on the mechanisms responsible for B cell migration, selection, and differentiation within and between specialized anatomical sites, particularly within lymphoid follicles, might be used to target suitable Env epitopes to appropriate B cell inductive pathways. An example would be to provide necessary signals to generate long-lived and high affinity memory in the marginal zone B cell compartment. Another example would be to discover ways to modify germinal center formation, positive and negative selection, and B cell differentiation to drive long-lived high affinity antibody responses against key epitopes that tend to be poorly immunogenic.</p><p id="__p16">In parallel to these efforts, genetic studies at the population level could provide critical information on the most promising paths to follow. In particular, the recent completion of the International HapMap Project now permits whole genome associated studies to be conducted with a minimum number of single nucleotide polymorphism tags [<a href="#pmed-0040348-b055" rid="pmed-0040348-b055" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423037">55</a>,<a href="#pmed-0040348-b056" rid="pmed-0040348-b056" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423022">56</a>]. This powerful new technology could be used to identify genes that are associated with the wide variation in neutralizing antibody responses in HIV-1-infected individuals and in vaccine recipients. A critical question to ask is whether the potent neutralizing antibody response in a small subset of infected individuals is due to unique viral epitopes or to host genetic polymorphisms. Current evidence suggests that both might make a substantial contribution in the context of combined epitope and allelic representations [<a href="#pmed-0040348-b028" rid="pmed-0040348-b028" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423020">28</a>,<a href="#pmed-0040348-b047" rid="pmed-0040348-b047" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423021">47</a>,<a href="#pmed-0040348-b057" rid="pmed-0040348-b057" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_620423013">57</a>].</p><p id="__p17">To date most studies of the humoral responses in HIV infections have investigated immunoglobulins, the final product of B cell responses. Relatively few studies have examined B cell immunopathogenesis. A number of basic questions are still unanswered (e.g., extent and reason for perturbation of B cell subset changes, including memory B cells and plasma cells, in peripheral blood and tissues). Questions also remain about other potential functional contributions of B cells to HIV infections (e.g., role as antigen-presenting cells). In vivo studies should be performed in the nonhuman primate animal model to determine the emergence of pathologic events in the B cell compartment, in particular in lymphatic and gastrointestinal tissues of na&#x000ef;ve and vaccinated animals that are challenged with pathogenic SIV or SHIV. These investigations should be done in parallel to detailed analyses of the magnitude and function of HIV-specific immunoglobulin responses determined in plasma and tissue secretions, and of HIV-specific B cells on a single cell basis.</p><p id="__p18" class="p p-last">The establishment of a research consortium to study fundamental B cell biology as it relates to HIV-1 vaccines is recommended. This program should be structured in a way that asks key scientific questions about B cell regulatory pathways that modulate Env immunogenicity. Studies could address B cell receptor&#x02013;ligand interactions and intracellular signaling pathways that govern the production of antibody-producing plasma cells, the persistence of plasma and memory B cells, the mechanism of action of adjuvants, and host genetic associations with immune responses.</p></div><div id="idm139650168801408" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139650168801408title">Acknowledgments</h2><div class="sec"><p id="__p19">We thank Paul Pelphs for serving as rapporteur of the workshop.</p></div></div><div id="idm139650093210256" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139650093210256title">Glossary</h2><div class="bk-sec"><div><h4>Abbreviations</h4><table class="default-table glossary"><tbody><tr><td>FcR</td><td>Fc receptor</td></tr><tr><td>MAb</td><td>monoclonal antibody</td></tr><tr><td>PBMC</td><td>peripheral blood mononuclear cells</td></tr><tr><td>SHIV</td><td>chimeric simian-human immunodeficiency virus</td></tr><tr><td>SIV</td><td>simian immunodeficiency virus</td></tr></tbody></table></div></div></div><div id="idm139650168800784" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139650168800784title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="n3"><p id="__p20" class="p p-first-last">David Montefiori is at Duke University Medical Center, Durham, North Carolina, United States of America. Quentin Sattentau is at University of Oxford, Oxford, United Kingdom. Jorge Flores is at the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. Jos&#x000e9; Esparza is at the Bill &#x00026; Melinda Gates Foundation, Seattle, Washington, United States of America. John Mascola is at the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.</p></p><div><p id="__p21" class="p p-first-last">\n<strong>Author contributions.</strong> DM, QS, and JM organized the Enterprise workshop with the collaboration of JF and JE, and all of them contributed to writing the paper. Participants in the workshop contributed with formal presentations, discussions, and editing of the paper. The other members of the Enterprise Working Group were: James Bradac, Donald S. Burke, Emily Carrow, Robert Carter, Andrea Cerutti, Raphaelle El Habib, Donald N. Forthal, Barton F. Haynes, Gunilla Karlsson Hedestam, Peter Kwong, Christiane Moog, Victoria R. Polonis, Helen Quill, Gabriella Scarlatti, J&#x000f6;rn Schmitz, George M. Shaw, Sriram Subramaniam, Gerald Voss, Drew Weisman, and Richard Wyatt.</p></div><p class="fn sec" id="n1"><p id="__p22" class="p p-first-last">\n<strong>Funding:</strong> Participation in the workshop was funded by the Global HIV Vaccine Enterprise. The authors received no additional funding for this article.</p></p><p class="fn sec" id="n2"><p id="__p23" class="p p-first-last">\n<strong>Competing Interests:</strong> The authors have declared that no competing interests exist.</p></p></div></div><div id="idm139650098775968" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139650098775968title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="pmed-0040348-b001"><span class="element-citation">Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise. The Global HIV/AIDS Vaccine Enterprise: Scientific strategic plan. <span><span class="ref-journal">PLoS Med. </span>2005;<span class="ref-vol">2</span>:e25. </span> doi: <span>10.1371/journal.pmed.0020025</span>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC544553/">PMC free article</a>]</span> [<a href="/pubmed/15740411" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Med&amp;title=The+Global+HIV/AIDS+Vaccine+Enterprise:+Scientific+strategic+plan&amp;volume=2&amp;publication_year=2005&amp;pages=e25&amp;pmid=15740411&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b002"><span class="element-citation">Mascola JR, D\'Souza P, Gilbert P, Hahn B, Haigwood NL, et al.  Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. <span><span class="ref-journal">J Virol. </span>2005;<span class="ref-vol">79</span>:10103\xe2\x80\x9310107.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1182642/">PMC free article</a>]</span> [<a href="/pubmed/16051803" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Recommendations+for+the+design+and+use+of+standard+virus+panels+to+assess+neutralizing+antibody+responses+elicited+by+candidate+human+immunodeficiency+virus+type+1+vaccines&amp;volume=79&amp;publication_year=2005&amp;pages=10103-10107&amp;pmid=16051803&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b003"><span class="element-citation">Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens. <span><span class="ref-journal">Science. </span>1998;<span class="ref-vol">280</span>:1884\xe2\x80\x931888.</span> [<a href="/pubmed/9632381" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+HIV-1+envelope+glycoproteins:+Fusogens,+antigens,+and+immunogens&amp;volume=280&amp;publication_year=1998&amp;pages=1884-1888&amp;pmid=9632381&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b004"><span class="element-citation">Crooks ET, Moore PL, Richman D, Robinson J, Crooks JA, et al.  Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. <span><span class="ref-journal">Hum Antibodies. </span>2005;<span class="ref-vol">14</span>:101\xe2\x80\x93113.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2630880/">PMC free article</a>]</span> [<a href="/pubmed/16720980" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Antibodies&amp;title=Characterizing+anti-HIV+monoclonal+antibodies+and+immune+sera+by+defining+the+mechanism+of+neutralization&amp;volume=14&amp;publication_year=2005&amp;pages=101-113&amp;pmid=16720980&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b005"><span class="element-citation">Moore PL, Crooks ET, Porter L, Porter L, Zhu P, et al.  The nature of non-functional envelope proteins on the surface of human immunodeficiency virus type 1. <span><span class="ref-journal">J Virol. </span>2006;<span class="ref-vol">80</span>:2515\xe2\x80\x932528.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1395414/">PMC free article</a>]</span> [<a href="/pubmed/16474158" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=The+nature+of+non-functional+envelope+proteins+on+the+surface+of+human+immunodeficiency+virus+type+1&amp;volume=80&amp;publication_year=2006&amp;pages=2515-2528&amp;pmid=16474158&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b006"><span class="element-citation">Wei X, Decker JM, Wang S, Hui H, Kappes JC, et al.  Antibody neutralization and escape by HIV-1. <span><span class="ref-journal">Nature. </span>2003;<span class="ref-vol">422</span>:307\xe2\x80\x93312.</span> [<a href="/pubmed/12646921" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Antibody+neutralization+and+escape+by+HIV-1&amp;volume=422&amp;publication_year=2003&amp;pages=307-312&amp;pmid=12646921&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b007"><span class="element-citation">Bou-Habib DC, Roderiquez G, Oravecz, T, Berman, PW, Lusso P, et al.  Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. <span><span class="ref-journal">J Virol. </span>1994;<span class="ref-vol">68</span>:6006\xe2\x80\x936013.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC237005/">PMC free article</a>]</span> [<a href="/pubmed/8057475" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Cryptic+nature+of+envelope+V3+region+epitopes+protects+primary+monocytotropic+human+immunodeficiency+virus+type+1+from+antibody+neutralization&amp;volume=68&amp;publication_year=1994&amp;pages=6006-6013&amp;pmid=8057475&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b008"><span class="element-citation">Cao J, Sullivan N, Desjardin E, Parolin C, Robinson J, et al.  Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. <span><span class="ref-journal">J Virol. </span>1997;<span class="ref-vol">71</span>:9808\xe2\x80\x939812.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC230295/">PMC free article</a>]</span> [<a href="/pubmed/9371651" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Replication+and+neutralization+of+human+immunodeficiency+virus+type+1+lacking+the+V1+and+V2+variable+loops+of+the+gp120+envelope+glycoprotein&amp;volume=71&amp;publication_year=1997&amp;pages=9808-9812&amp;pmid=9371651&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b009"><span class="element-citation">Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, et al.  Structure of an HIVgp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. <span><span class="ref-journal">Nature. </span>1998;<span class="ref-vol">393</span>:648\xe2\x80\x93659.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5629912/">PMC free article</a>]</span> [<a href="/pubmed/9641677" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structure+of+an+HIVgp120+envelope+glycoprotein+in+complex+with+the+CD4+receptor+and+a+neutralizing+human+antibody&amp;volume=393&amp;publication_year=1998&amp;pages=648-659&amp;pmid=9641677&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b010"><span class="element-citation">Kwong PD, Wyatt R, Majeed S, Robinson J, Sweet RW, et al.  Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. <span><span class="ref-journal">Struct Fold Des. </span>2000;<span class="ref-vol">8</span>:1329\xe2\x80\x931339.</span> [<a href="/pubmed/11188697" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Struct+Fold+Des&amp;title=Structures+of+HIV-1+gp120+envelope+glycoproteins+from+laboratory-adapted+and+primary+isolates&amp;volume=8&amp;publication_year=2000&amp;pages=1329-1339&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b011"><span class="element-citation">Chen B, Vogan EM, Gong H, Skehel JJ, Wiley DC, et al.  Structure of an unliganded simian immunodeficiency virus gp120 core. <span><span class="ref-journal">Nature. </span>2005;<span class="ref-vol">433</span>:834\xe2\x80\x93841.</span> [<a href="/pubmed/15729334" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structure+of+an+unliganded+simian+immunodeficiency+virus+gp120+core&amp;volume=433&amp;publication_year=2005&amp;pages=834-841&amp;pmid=15729334&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b012"><span class="element-citation">Huang C-C, Tang M, Zhang MY, Majeed S, Montabana E, et al.  Structure of a V3-containing HIV-1 gp120 core. <span><span class="ref-journal">Science. </span>2005;<span class="ref-vol">310</span>:1025\xe2\x80\x931028.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2408531/">PMC free article</a>]</span> [<a href="/pubmed/16284180" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Structure+of+a+V3-containing+HIV-1+gp120+core&amp;volume=310&amp;publication_year=2005&amp;pages=1025-1028&amp;pmid=16284180&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b013"><span class="element-citation">Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, et al.  Structural definition of a conserved neutralization epitope on HIV-1 gp120. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">445</span>:732\xe2\x80\x93737.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2584968/">PMC free article</a>]</span> [<a href="/pubmed/17301785" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structural+definition+of+a+conserved+neutralization+epitope+on+HIV-1+gp120&amp;volume=445&amp;publication_year=2007&amp;pages=732-737&amp;pmid=17301785&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b014"><span class="element-citation">Zhu P, Liu J, Bess J, Jr, Chertova E, Lifson JD, et al.  Distribution and three-dimensional structure of AIDS virus envelope spikes. <span><span class="ref-journal">Nature. </span>2006;<span class="ref-vol">441</span>:847\xe2\x80\x93852.</span> [<a href="/pubmed/16728975" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Distribution+and+three-dimensional+structure+of+AIDS+virus+envelope+spikes&amp;volume=441&amp;publication_year=2006&amp;pages=847-852&amp;pmid=16728975&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b015"><span class="element-citation">Zanetti G, Briggs JAG, Gr&#x000fc;newald K, Sattentau QJ, Fuller SD. Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ. <span><span class="ref-journal">PLoS Pathog. </span>2006;<span class="ref-vol">2</span>:e83. </span> doi: <span>10.1371/journal.ppat.0020083</span>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1557830/">PMC free article</a>]</span> [<a href="/pubmed/16933990" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Pathog&amp;title=Cryo-electron+tomographic+structure+of+an+immunodeficiency+virus+envelope+complex+in+situ&amp;volume=2&amp;publication_year=2006&amp;pages=e83&amp;pmid=16933990&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b016"><span class="element-citation">Sougrat R, Bartesaghi A, Lifson JD, Bennett AE, Bess JW, et al.  Electron tomography of the contact between T cells and SIV/HIV&#x02013;1: Implications for viral entry. <span><span class="ref-journal">PLoS Pathog. </span>2007;<span class="ref-vol">3</span>:e63. </span> doi: <span>10.1371/journal.ppat.0030063</span>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1864992/">PMC free article</a>]</span> [<a href="/pubmed/17480119" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Pathog&amp;title=Electron+tomography+of+the+contact+between+T+cells+and+SIV/HIV&#x02013;1:+Implications+for+viral+entry&amp;volume=3&amp;publication_year=2007&amp;pages=e63&amp;pmid=17480119&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b017"><span class="element-citation">Pantophlet R, Burton DR. GP120: Target for neutralizing HIV-1 antibodies. <span><span class="ref-journal">Annu Rev Immunol. </span>2006;<span class="ref-vol">24</span>:739\xe2\x80\x93769.</span> [<a href="/pubmed/16551265" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Immunol&amp;title=GP120:+Target+for+neutralizing+HIV-1+antibodies&amp;volume=24&amp;publication_year=2006&amp;pages=739-769&amp;pmid=16551265&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b018"><span class="element-citation">Haynes BF, Montefiori DC. Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. <span><span class="ref-journal">Expert Rev Vaccines. </span>2006;<span class="ref-vol">5</span>:347\xe2\x80\x93363.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2716009/">PMC free article</a>]</span> [<a href="/pubmed/16827619" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Rev+Vaccines&amp;title=Aiming+to+induce+broadly+reactive+neutralizing+antibody+responses+with+HIV-1+vaccine+candidates&amp;volume=5&amp;publication_year=2006&amp;pages=347-363&amp;pmid=16827619&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b019"><span class="element-citation">Phogat S, Wyatt R. Rational modifications of HIV-1 envelope glycoproteins for immunogen design. <span><span class="ref-journal">Cur Pharm Design. </span>2007;<span class="ref-vol">13</span>:213\xe2\x80\x93227.</span> [<a href="/pubmed/17269929" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cur+Pharm+Design&amp;title=Rational+modifications+of+HIV-1+envelope+glycoproteins+for+immunogen+design&amp;volume=13&amp;publication_year=2007&amp;pages=213-227&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b020"><span class="element-citation">Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, et al.  HIV vaccine design and the neutralizing antibody problem. <span><span class="ref-journal">Nat Med. </span>2004;<span class="ref-vol">5</span>:233\xe2\x80\x93236.</span> [<a href="/pubmed/14985706" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=HIV+vaccine+design+and+the+neutralizing+antibody+problem&amp;volume=5&amp;publication_year=2004&amp;pages=233-236&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b021"><span class="element-citation">Haynes BF, Moody MA, Verkoczy L, Kelsoe G, Munir SM. Antibody polyspecificity and neutralization of HIV-1: A hypothesis. <span><span class="ref-journal">Hum Antibodies. </span>2005;<span class="ref-vol">14</span>:59\xe2\x80\x9367.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2673565/">PMC free article</a>]</span> [<a href="/pubmed/16720975" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Antibodies&amp;title=Antibody+polyspecificity+and+neutralization+of+HIV-1:+A+hypothesis&amp;volume=14&amp;publication_year=2005&amp;pages=59-67&amp;pmid=16720975&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b022"><span class="element-citation">Bowley DR, Labrijn AF, Zwick MB, Burton DR. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage. <span><span class="ref-journal">Protein Eng Design Selection. </span>2007;<span class="ref-vol">20</span>:81090.</span> [<a href="/pubmed/17242026" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Protein+Eng+Design+Selection&amp;title=Antigen+selection+from+an+HIV-1+immune+antibody+library+displayed+on+yeast+yields+many+novel+antibodies+compared+to+selection+from+the+same+library+displayed+on+phage&amp;volume=20&amp;publication_year=2007&amp;pages=81090&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b023"><span class="element-citation">Traggiai E, Becker S, Subbarao, K, Kolesnikova L, Uematsu Y, et al.  An efficient method to make human monoclonal antibodies from memory B cells: Potent neutralization of SARS coronavirus. <span><span class="ref-journal">Nat Med. </span>2004;<span class="ref-vol">10</span>:871\xe2\x80\x93875.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7095806/">PMC free article</a>]</span> [<a href="/pubmed/15247913" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=An+efficient+method+to+make+human+monoclonal+antibodies+from+memory+B+cells:+Potent+neutralization+of+SARS+coronavirus&amp;volume=10&amp;publication_year=2004&amp;pages=871-875&amp;pmid=15247913&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b024"><span class="element-citation">Yuste E, Sanford HB, Carmody J, Bixby J, Little S, et al.  Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: Replication, neutralization, and survey of HIV-1-positive sera. <span><span class="ref-journal">J Virol. </span>2006;<span class="ref-vol">80</span>:3030\xe2\x80\x933041.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1395451/">PMC free article</a>]</span> [<a href="/pubmed/16501112" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Simian+immunodeficiency+virus+engrafted+with+human+immunodeficiency+virus+type+1+(HIV-1)-specific+epitopes:+Replication,+neutralization,+and+survey+of+HIV-1-positive+sera&amp;volume=80&amp;publication_year=2006&amp;pages=3030-3041&amp;pmid=16501112&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b025"><span class="element-citation">Li Y, Migueles S, Welcher B, Svehla K, Phogart A, et al.  Broad HIV-1 neutralization mediated by CD4 binding site antibodies. <span><span class="ref-journal">Nat Med. </span>2007;<span class="ref-vol">13</span>:1032\xe2\x80\x931034.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2584972/">PMC free article</a>]</span> [<a href="/pubmed/17721546" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Broad+HIV-1+neutralization+mediated+by+CD4+binding+site+antibodies&amp;volume=13&amp;publication_year=2007&amp;pages=1032-1034&amp;pmid=17721546&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b026"><span class="element-citation">Dhillon AK, Donners H, Pantophlet R, Johnson WE, Decker JM, et al.  Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors. <span><span class="ref-journal">J Virol. </span>2007;<span class="ref-vol">81</span>:6548\xe2\x80\x936562.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1900098/">PMC free article</a>]</span> [<a href="/pubmed/17409160" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Dissecting+the+neutralizing+antibody+specificities+of+broadly+neutralizing+sera+from+human+immunodeficiency+virus+type+1-infected+donors&amp;volume=81&amp;publication_year=2007&amp;pages=6548-6562&amp;pmid=17409160&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b027"><span class="element-citation">Deeks SG, Schweighardt B, Wrin T, Galovich J, Hoh R, et al.  Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: Evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses. <span><span class="ref-journal">J Virol. </span>2006;<span class="ref-vol">80</span>:6155\xe2\x80\x936164.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1472617/">PMC free article</a>]</span> [<a href="/pubmed/16731954" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Neutralizing+antibody+responses+against+autologous+and+heterologous+viruses+in+acute+versus+chronic+human+immunodeficiency+virus+(HIV)+infection:+Evidence+for+a+constraint+on+the+ability+of+HIV+to+completely+evade+neutralizing+antibody+responses&amp;volume=80&amp;publication_year=2006&amp;pages=6155-6164&amp;pmid=16731954&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b028"><span class="element-citation">Draenert R, Allen TM, Liu Y, Wrin T, Chappey C, et al.  Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus. <span><span class="ref-journal">J Exp Med. </span>2006;<span class="ref-vol">203</span>:529\xe2\x80\x93539.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2118231/">PMC free article</a>]</span> [<a href="/pubmed/16533886" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Constraints+on+HIV-1+evolution+and+immunodominance+revealed+in+monozygotic+adult+twins+infected+with+the+same+virus&amp;volume=203&amp;publication_year=2006&amp;pages=529-539&amp;pmid=16533886&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b029"><span class="element-citation">Montefiori DC, Graham BS, Zhou JT, Zhou JY, Bucco R, et al.  V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding region of gp120. <span><span class="ref-journal">J Clin Invest. </span>1993;<span class="ref-vol">92</span>:840\xe2\x80\x93847.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC294922/">PMC free article</a>]</span> [<a href="/pubmed/8349820" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=V3-specific+neutralizing+antibodies+in+sera+from+HIV-1+gp160-immunized+volunteers+block+virus+fusion+and+act+synergistically+with+human+monoclonal+antibody+to+the+conformation-dependent+CD4+binding+region+of+gp120&amp;volume=92&amp;publication_year=1993&amp;pages=840-847&amp;pmid=8349820&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b030"><span class="element-citation">Thali M, Furman C, Wahren B, Posner M, Ho DD, et al.  Cooperativity of neutralizing antibodies directed against the V3 and CD4 binding regions of the human immunodeficiency virus gp120 envelope glycoproteins. <span><span class="ref-journal">J Acquired Immune Defic Syndr. </span>1992;<span class="ref-vol">5</span>:591\xe2\x80\x93599.</span> [<a href="/pubmed/1588493" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Acquired+Immune+Defic+Syndr&amp;title=Cooperativity+of+neutralizing+antibodies+directed+against+the+V3+and+CD4+binding+regions+of+the+human+immunodeficiency+virus+gp120+envelope+glycoproteins&amp;volume=5&amp;publication_year=1992&amp;pages=591-599&amp;pmid=1588493&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b031"><span class="element-citation">Tilley SA, Honnen WJ, Racho ME, Chou T-C, Pinter A. Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120. <span><span class="ref-journal">AIDS Res Hum Retroviruses. </span>1992;<span class="ref-vol">8</span>:461\xe2\x80\x93467.</span> [<a href="/pubmed/1376135" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AIDS+Res+Hum+Retroviruses&amp;title=Synergistic+neutralization+of+HIV-1+by+human+monoclonal+antibodies+against+the+V3+loop+and+the+CD4-binding+site+of+gp120&amp;volume=8&amp;publication_year=1992&amp;pages=461-467&amp;pmid=1376135&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b032"><span class="element-citation">Li A, Katinger H, Posner MR, Cavacini L, Zolla-Pazner S, et al.  Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu&#x0002b; by triple and quaduple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins. <span><span class="ref-journal">J Virol. </span>1998;<span class="ref-vol">72</span>:3235\xe2\x80\x933240.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC109792/">PMC free article</a>]</span> [<a href="/pubmed/9525650" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Synergistic+neutralization+of+simian-human+immunodeficiency+virus+SHIV-vpu&#x0002b;+by+triple+and+quaduple+combinations+of+human+monoclonal+antibodies+and+high-titer+anti-human+immunodeficiency+virus+type+1+immunoglobulins&amp;volume=72&amp;publication_year=1998&amp;pages=3235-3240&amp;pmid=9525650&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b033"><span class="element-citation">Sullivan N, Sun Y, Sattentau Q, Thali M, Wu D, et al.  CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. <span><span class="ref-journal">J Virol. </span>1998;<span class="ref-vol">72</span>:4694\xe2\x80\x934703.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC109994/">PMC free article</a>]</span> [<a href="/pubmed/9573233" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=CD4-induced+conformational+changes+in+the+human+immunodeficiency+virus+type+1+gp120+glycoprotein:+consequences+for+virus+entry+and+neutralization&amp;volume=72&amp;publication_year=1998&amp;pages=4694-4703&amp;pmid=9573233&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b034"><span class="element-citation">Decker J, Bibollet-Ruche F, Wei X, Wang S, Levy DN, et al.  Antigenic conservation and immunogenicity of the HIV coreceptor binding site. <span><span class="ref-journal">J Exp Med. </span>2005;<span class="ref-vol">201</span>:1407\xe2\x80\x931419.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2213183/">PMC free article</a>]</span> [<a href="/pubmed/15867093" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Antigenic+conservation+and+immunogenicity+of+the+HIV+coreceptor+binding+site&amp;volume=201&amp;publication_year=2005&amp;pages=1407-1419&amp;pmid=15867093&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b035"><span class="element-citation">Forthal DN, Landucci G, Stefano-Cole K, Marthas M, Becerra JC, et al.  Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells. <span><span class="ref-journal">J Virol. </span>2006;<span class="ref-vol">80</span>:9217\xe2\x80\x939225.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1563916/">PMC free article</a>]</span> [<a href="/pubmed/16940533" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Rhesus+macaque+polyclonal+and+monoclonal+antibodies+inhibit+simian+immunodeficiency+virus+in+the+presence+of+human+or+autologous+rhesus+effector+cells&amp;volume=80&amp;publication_year=2006&amp;pages=9217-9225&amp;pmid=16940533&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b036"><span class="element-citation">Gomez-Roman VR, Patterson LJ, Venson D, Liewehr D, Aldrich K, et al.  Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIV. <span><span class="ref-journal">J Immunol. </span>2005;<span class="ref-vol">174</span>:2185\xe2\x80\x932189.</span> [<a href="/pubmed/15699150" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Vaccine-elicited+antibodies+mediate+antibody-dependent+cellular+cytotoxicity+correlated+with+significantly+reduced+acute+viremia+in+rhesus+macaques+challenged+with+SIV&amp;volume=174&amp;publication_year=2005&amp;pages=2185-2189&amp;pmid=15699150&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b037"><span class="element-citation">Aasa-Chapman MMI, Holuigue S, Aubin K, Wong M, Jones NA, et al.  Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection. <span><span class="ref-journal">J Virol. </span>2005;<span class="ref-vol">79</span>:2823\xe2\x80\x932830.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC548453/">PMC free article</a>]</span> [<a href="/pubmed/15709001" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Detection+of+antibody-dependent+complement-mediated+inactivation+of+both+autologous+and+heterologous+virus+in+primary+human+immunodeficiency+virus+type+1+infection&amp;volume=79&amp;publication_year=2005&amp;pages=2823-2830&amp;pmid=15709001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b038"><span class="element-citation">Huber M, Fischer M, Misselwitz B, Manrique A, Kuster H, et al.  Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection. <span><span class="ref-journal">PLoS Med. </span>2006;<span class="ref-vol">3</span>:e441. </span> doi: <span>10.1371/journal.pmed.0030441</span>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1637124/">PMC free article</a>]</span> [<a href="/pubmed/17121450" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Med&amp;title=Complement+lysis+activity+in+autologous+plasma+is+associated+with+lower+viral+loads+during+the+acute+phase+of+HIV-1+infection&amp;volume=3&amp;publication_year=2006&amp;pages=e441&amp;pmid=17121450&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b039"><span class="element-citation">Holl V, Peressin M, Schmidt S, Decoville T, Zolla-Pasner S, et al.  Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">107</span>:4466\xe2\x80\x934474.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1895798/">PMC free article</a>]</span> [<a href="/pubmed/16469871" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Efficient+inhibition+of+HIV-1+replication+in+human+immature+monocyte-derived+dendritic+cells+by+purified+anti-HIV-1+IgG+without+induction+of+maturation&amp;volume=107&amp;publication_year=2006&amp;pages=4466-4474&amp;pmid=16469871&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b040"><span class="element-citation">Holl V, Peressin M, Decoville T, Schmidt S, Zolla-Pazner S, et al.  Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type l replication in macrophages and immature dendritic cells. <span><span class="ref-journal">J Virol. </span>2006;<span class="ref-vol">80</span>:6177\xe2\x80\x936181.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1472578/">PMC free article</a>]</span> [<a href="/pubmed/16731957" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Nonneutralizing+antibodies+are+able+to+inhibit+human+immunodeficiency+virus+type+l+replication+in+macrophages+and+immature+dendritic+cells&amp;volume=80&amp;publication_year=2006&amp;pages=6177-6181&amp;pmid=16731957&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b041"><span class="element-citation">Hessell AJ, Hangartner L, Hunter M, Havenith CEG, Beurskens FJ, et al.  Fc receptor but not complement binding is important in antibody protection against HIV. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">449</span>:101\xe2\x80\x93105.</span> [<a href="/pubmed/17805298" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Fc+receptor+but+not+complement+binding+is+important+in+antibody+protection+against+HIV&amp;volume=449&amp;publication_year=2007&amp;pages=101-105&amp;pmid=17805298&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b042"><span class="element-citation">Li M, Salazar-Gonzalez JF, Derdeyn CA, Morris L, Williamson C, et al.  Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. <span><span class="ref-journal">J Virol. </span>2006;<span class="ref-vol">80</span>:11776\xe2\x80\x9311790.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1642599/">PMC free article</a>]</span> [<a href="/pubmed/16971434" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Genetic+and+neutralization+properties+of+subtype+C+human+immunodeficiency+virus+type+1+molecular+env+clones+from+acute+and+early+heterosexually+acquired+infections+in+Southern+Africa&amp;volume=80&amp;publication_year=2006&amp;pages=11776-11790&amp;pmid=16971434&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b043"><span class="element-citation">Binley J, Wrin T, Korber B, Zwick M, Wang M, et al.  Comprehensive cross-subtype neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. <span><span class="ref-journal">J Virol. </span>2004;<span class="ref-vol">78</span>:13232\xe2\x80\x9313252.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC524984/">PMC free article</a>]</span> [<a href="/pubmed/15542675" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Comprehensive+cross-subtype+neutralization+analysis+of+a+panel+of+anti-human+immunodeficiency+virus+type+1+monoclonal+antibodies&amp;volume=78&amp;publication_year=2004&amp;pages=13232-13252&amp;pmid=15542675&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b044"><span class="element-citation">Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, et al.  Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. <span><span class="ref-journal">J Virol. </span>2005;<span class="ref-vol">79</span>:10108\xe2\x80\x9310125.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1182643/">PMC free article</a>]</span> [<a href="/pubmed/16051804" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Human+immunodeficiency+virus+type+1+env+clones+from+acute+and+early+subtype+B+infections+for+standardized+assessments+of+vaccine-elicited+neutralizing+antibodies&amp;volume=79&amp;publication_year=2005&amp;pages=10108-10125&amp;pmid=16051804&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b045"><span class="element-citation">Richman DD, Wrin T, Little SJ, Petropoulos CJ. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:4144\xe2\x80\x934149.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC153062/">PMC free article</a>]</span> [<a href="/pubmed/12644702" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Rapid+evolution+of+the+neutralizing+antibody+response+to+HIV+type+1+infection&amp;volume=100&amp;publication_year=2003&amp;pages=4144-4149&amp;pmid=12644702&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b046"><span class="element-citation">Brown BK, Karasavvas N, Beck Z, Matyas GR, Birx DL, et al.  Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: Role of phosphate-binding substrates. <span><span class="ref-journal">J Virol. </span>2007;<span class="ref-vol">81</span>:2087\xe2\x80\x932091.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1797582/">PMC free article</a>]</span> [<a href="/pubmed/17151131" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Monoclonal+antibodies+to+phosphatidylinositol+phosphate+neutralize+human+immunodeficiency+virus+type+1:+Role+of+phosphate-binding+substrates&amp;volume=81&amp;publication_year=2007&amp;pages=2087-2091&amp;pmid=17151131&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b047"><span class="element-citation">Choudhry V, Zhang M-Y, Sidrov IA, Bouma P, Cham F, et al.  Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolate from a patient (R2) with broadly HIV-1 neutralizing antibodies. <span><span class="ref-journal">Virology. </span>2007;<span class="ref-vol">363</span>:79\xe2\x80\x9390.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2696119/">PMC free article</a>]</span> [<a href="/pubmed/17306322" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Cross-reactive+HIV-1+neutralizing+monoclonal+antibodies+selected+by+screening+of+an+immune+human+phage+library+against+an+envelope+glycoprotein+(gp140)+isolate+from+a+patient+(R2)+with+broadly+HIV-1+neutralizing+antibodies&amp;volume=363&amp;publication_year=2007&amp;pages=79-90&amp;pmid=17306322&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b048"><span class="element-citation">Hu S-L. Non-human primate models for AIDS vaccine research. <span><span class="ref-journal">Curr Drug Targets. </span>2005;<span class="ref-vol">5</span>:193\xe2\x80\x93201.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1488817/">PMC free article</a>]</span> [<a href="/pubmed/15975024" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Targets&amp;title=Non-human+primate+models+for+AIDS+vaccine+research&amp;volume=5&amp;publication_year=2005&amp;pages=193-201&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b049"><span class="element-citation">Feinberg MB, Moore JP. AIDS vaccine models: Challenging challenge viruses. <span><span class="ref-journal">Nat Med. </span>2002;<span class="ref-vol">8</span>:1\xe2\x80\x934.</span> [<a href="/pubmed/11875482" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=AIDS+vaccine+models:+Challenging+challenge+viruses&amp;volume=8&amp;publication_year=2002&amp;pages=1-4&amp;pmid=11786879&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b050"><span class="element-citation">Haynes B, Fleming J, St. Clair E, Katinger H, Steigler G, et al.  0 Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. <span><span class="ref-journal">Science. </span>2005;<span class="ref-vol">308</span>:1906\xe2\x80\x931908.</span> [<a href="/pubmed/15860590" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=0+Cardiolipin+polyspecific+autoreactivity+in+two+broadly+neutralizing+HIV-1+antibodies&amp;volume=308&amp;publication_year=2005&amp;pages=1906-1908&amp;pmid=15860590&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b051"><span class="element-citation">Alam SM, McAdams M, Boren D, Rak M, Scearce RM, et al.  The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. <span><span class="ref-journal">J Immunol. </span>2007;<span class="ref-vol">178</span>:4424\xe2\x80\x934435.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2262928/">PMC free article</a>]</span> [<a href="/pubmed/17372000" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=The+role+of+antibody+polyspecificity+and+lipid+reactivity+in+binding+of+broadly+neutralizing+anti-HIV-1+envelope+human+monoclonal+antibodies+2F5+and+4E10+to+glycoprotein+41+membrane+proximal+envelope+epitopes&amp;volume=178&amp;publication_year=2007&amp;pages=4424-4435&amp;pmid=17372000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b052"><span class="element-citation">Fernando K, Hu H, Ni H, Hoxie JA, Weissman D. Vaccine-delivered HIV envelope inhibits CD4<sup>&#x0002b;</sup> T&#x02013;cell activation, a mechanism for poor HIV vaccine responses. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">109</span>:2538\xe2\x80\x932544.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1852208/">PMC free article</a>]</span> [<a href="/pubmed/17158230" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Vaccine-delivered+HIV+envelope+inhibits+CD4&#x0002b;+T&#x02013;cell+activation,+a+mechanism+for+poor+HIV+vaccine+responses&amp;volume=109&amp;publication_year=2007&amp;pages=2538-2544&amp;pmid=17158230&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b053"><span class="element-citation">He B, Qiao X, Kalsse PJ, Chiu A, Chadburn A, et al.  HIV-1 envelope triggers polyclonal Ig class switch recombination through CD4-independent mechanism involving BAFF and C-type lectin receptors. <span><span class="ref-journal">J Immunol. </span>2006;<span class="ref-vol">176</span>:3931\xe2\x80\x933941.</span> [<a href="/pubmed/16547227" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=HIV-1+envelope+triggers+polyclonal+Ig+class+switch+recombination+through+CD4-independent+mechanism+involving+BAFF+and+C-type+lectin+receptors&amp;volume=176&amp;publication_year=2006&amp;pages=3931-3941&amp;pmid=16547227&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b054"><span class="element-citation">Binley JM, Klasse PJ, Cao Y, Jones I, Markowitz M, et al.  Differential regulation of the antibody response to gag and Env proteins of human immunodeficiency virus type 1. <span><span class="ref-journal">J Virol. </span>1997;<span class="ref-vol">71</span>:2799\xe2\x80\x932809.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC191404/">PMC free article</a>]</span> [<a href="/pubmed/9060635" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Differential+regulation+of+the+antibody+response+to+gag+and+Env+proteins+of+human+immunodeficiency+virus+type+1&amp;volume=71&amp;publication_year=1997&amp;pages=2799-2809&amp;pmid=9060635&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b055"><span class="element-citation">Conrad DF, Jakobsson M, Coop G, Wen X, Wall JD, et al.  A worldwide survey of haplotype variation and linkage disequilibrium in the human genome. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:1251\xe2\x80\x931260.</span> [<a href="/pubmed/17057719" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+worldwide+survey+of+haplotype+variation+and+linkage+disequilibrium+in+the+human+genome&amp;volume=38&amp;publication_year=2006&amp;pages=1251-1260&amp;pmid=17057719&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b056"><span class="element-citation">de Bakker PIW, Burtt NP, Graham RR, Guiducci C, Yelensky R, et al.  Transferability of tag SNPs in genetic association studies in multiple populations. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:1298\xe2\x80\x931303.</span> [<a href="/pubmed/17057720" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Transferability+of+tag+SNPs+in+genetic+association+studies+in+multiple+populations&amp;volume=38&amp;publication_year=2006&amp;pages=1298-1303&amp;pmid=17057720&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="pmed-0040348-b057"><span class="element-citation">Zhang PF, Cham F, Dong M, Choudhary A, Bouma P, et al.  Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2007;<span class="ref-vol">104</span>:10193\xe2\x80\x9310198.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1885220/">PMC free article</a>]</span> [<a href="/pubmed/17540729" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Extensively+cross-reactive+anti-HIV-1+neutralizing+antibodies+induced+by+gp140+immunization&amp;volume=104&amp;publication_year=2007&amp;pages=10193-10198&amp;pmid=17540729&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2100141&amp;issue-id=160274&amp;journal-id=277&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">PLoS Medicine</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2100141/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2100141/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2100141/pdf/pmed.0040348.pdf">PDF (101K)</a></li> | <li><a href="#" data-citationid="PMC2100141" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2100141%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2100141%2F&amp;text=Antibody-Based%20HIV-1%20Vaccines%3A%20Recent%20Developments%20and%20Future%20Directions"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2100141%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="18052607" data-aiid="2222942" data-aid="2100141" data-iid="160274" data-domainid="277" data-domain="plosmed" data-accid="PMC2100141" data-md5="8d5cfc971af5977196b31e4c8e65ead7"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:32:51-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1AB7E1E99A0FA100000000090C090B&amp;ncbi_session=8A1AB7E1E99B0021_2316SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2100141%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=plosmed&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2100141/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1AB7E1E99B0021_2316SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'